Cargando…

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges

Molecular characterization of individual patients’ tumor cells is becoming increasingly important in offering effective treatment for patients in clinical practice. Recent advances in the field have indicated that circulating tumor DNA (ctDNA) has huge potential to serve as a biomarker for early det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jia-Cheng, Feng, Yi-Li, Guo, Tao, Xie, An-Yong, Cai, Xiu-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866298/ https://www.ncbi.nlm.nih.gov/pubmed/27182434 http://dx.doi.org/10.1186/s13578-016-0100-z

Ejemplares similares

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
por: Dhayat, Sameer A., et al.
Publicado: (2020)

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA
por: Campani, Claudia, et al.
Publicado: (2023)

Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
por: Zhu, Gui‐Qi, et al.
Publicado: (2021)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma
por: von Felden, Johann, et al.
Publicado: (2018)

Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma
por: Bai, Tao, et al.
Publicado: (2020)

A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2023)

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Clinical applications of circulating tumor cells in hepatocellular carcinoma
por: Hua, Yinggang, et al.
Publicado: (2022)

Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
por: Jiang, Peiyong, et al.
Publicado: (2018)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
por: Chiappini, Franck
Publicado: (2012)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)

Detecting Circulating Tumor Cells: Current Challenges and New Trends
por: Hong, Bin, et al.
Publicado: (2013)

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2022)

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011)

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
por: Zhou, Kai-Qian, et al.
Publicado: (2020)

Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
por: Sun, Bin, et al.
Publicado: (2023)

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
por: Fujii, Yasutoshi, et al.
Publicado: (2021)

Research progress on circulating tumor cells of hepatocellular carcinoma
por: Wan, Chenyu, et al.
Publicado: (2021)

Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
por: Xu, Yuyan, et al.
Publicado: (2023)

Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma
por: Campo, David S., et al.
Publicado: (2019)

Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma
por: Guo, Wenbo, et al.
Publicado: (2021)

Circulating tumor DNA: current challenges for clinical utility
por: Dang, Donna K., et al.
Publicado: (2022)

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
por: Ribba, Benjamin, et al.
Publicado: (2023)

Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis
por: Zhang, Ziying, et al.
Publicado: (2019)

Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
por: Huang, Ao, et al.
Publicado: (2016)

Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
por: Yu, Jing-jing, et al.
Publicado: (2018)

Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, Jia Jie, et al.
Publicado: (2022)

Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma
por: Tao, Kaishan, et al.
Publicado: (2020)

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
por: Wu, Xiaolin, et al.
Publicado: (2020)

Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA
por: Labgaa, Ismail, et al.
Publicado: (2021)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

A dual biomarker detection platform for quantitating circulating tumor DNA (ctDNA)
por: Cai, Chunyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7fc9qvaln0702pv15vsp5usavg